Related Experiment Video
Updated: Apr 27, 2026
06:21
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
1.6K
GNAS1 mutation analysis in gastrointestinal tumors.
Bernhard Maria Walther, Ina Walther, Yuan Chen
1Institute of Pathology, University Hospital Jena, Friedrich-Schiller-University, Jena, Germany. iver.petersen@med.uni-jena.de.
Folia Histochemica Et Cytobiologica
|July 10, 2014
Summary
GNAS1 mutations are uncommon in gastrointestinal neuroendocrine tumors and hyperplastic polyps. However, this study found GNAS1 mutations in colon tumors exhibiting villous differentiation, suggesting a role in specific colorectal tumor subtypes.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- GNAS1 gene mutations are prevalent in myxoid soft tissue tumors.
- The mutation status of GNAS1 in gastrointestinal tumors remains largely uncharacterized.
Purpose of the Study:
- To investigate the frequency and distribution of GNAS1 mutations in various gastrointestinal tumors.
- Specifically analyze GNAS1 exon 8 in colorectal tumors, gastrointestinal neuroendocrine tumors (GEP-NETs), and related polyps.
Main Methods:
- Analysis of GNAS1 exon 8 in 135 formalin-fixed, paraffin-embedded gastrointestinal tumor samples.
- Utilized polymerase chain reaction (PCR) and direct sequencing for mutation detection.
Main Results:
- GNAS1 mutations were identified in 5 samples: 2 tubular-villous adenomas, 2 villous adenomas, and 1 colorectal adenocarcinoma.
- No GNAS1 mutations were detected in tubular adenomas, hyperplastic gastric polyps, or GEP-NETs.
Conclusions:
- GNAS1 mutations are infrequent in GEP-NETs and hyperplastic gastric polyps.
- The study confirms the presence of GNAS1 mutations in colorectal tumors with villous components, indicating potential involvement in their pathogenesis.
